Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Lung cancer immunotherapy: progress, pitfalls, and promises
A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Recent advances in non-small cell lung cancer targeted therapy; an update review
Lung cancer continues to be the leading cause of cancer-related death worldwide. In the last
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …
decade, significant advancements in the diagnosis and treatment of lung cancer, particularly …
Non‐small cell lung cancer in China
P Chen, Y Liu, Y Wen, C Zhou - Cancer Communications, 2022 - Wiley Online Library
In China, lung cancer is a primary cancer type with high incidence and mortality. Risk factors
for lung cancer include tobacco use, family history, radiation exposure, and the presence of …
for lung cancer include tobacco use, family history, radiation exposure, and the presence of …
Genomic–transcriptomic evolution in lung cancer and metastasis
Intratumour heterogeneity (ITH) fuels lung cancer evolution, which leads to immune evasion
and resistance to therapy. Here, using paired whole-exome and RNA sequencing data, we …
and resistance to therapy. Here, using paired whole-exome and RNA sequencing data, we …
Epidemiology of lung cancer
Lung cancer is the leading cause of global cancer incidence and mortality, accounting for an
estimated 2 million diagnoses and 1.8 million deaths. Neoplasms of the lungs are the …
estimated 2 million diagnoses and 1.8 million deaths. Neoplasms of the lungs are the …
Small-cell lung cancer
CM Rudin, E Brambilla, C Faivre-Finn… - Nature Reviews Disease …, 2021 - nature.com
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …
Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force
DE Jonas, DS Reuland, SM Reddy, M Nagle, SD Clark… - Jama, 2021 - jamanetwork.com
Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …
review the evidence on screening for lung cancer with low-dose computed tomography …
[HTML][HTML] Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment
Y Alduais, H Zhang, F Fan, J Chen, B Chen - Medicine, 2023 - journals.lww.com
Lung cancer remains the leading cause of cancer deaths. Non-small cell lung cancer
(NSCLC) is the most frequent subtype of lung cancer. Surgery, radiation, chemotherapy …
(NSCLC) is the most frequent subtype of lung cancer. Surgery, radiation, chemotherapy …
Lung cancer 2020: epidemiology, etiology, and prevention
BC Bade, CSD Cruz - Clinics in chest medicine, 2020 - chestmed.theclinics.com
Notable changes in lung cancer epidemiology and prevention have occurred over the past
decade owing to changes in smoking patterns, groundbreaking advances in our …
decade owing to changes in smoking patterns, groundbreaking advances in our …
Derivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learning
Methods of computational pathology applied to the analysis of whole-slide images (WSIs) do
not typically consider histopathological features from the tumour microenvironment. Here …
not typically consider histopathological features from the tumour microenvironment. Here …